Francesca Romana Prusciano
Francesca Romana Prusciano has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Pier Paolo Prontera
Department of Urology, “S.S. Annunziata” Hospital, Taranto
5 shared publications - Carmine Sciorio
Department of Urology, “Alessandro Manzoni” Hospital of Lecco
4 shared publications - Francesco Saverio Grossi
Department of Urology, “S.S. Annunziata” Hospital, Taranto
4 shared publications - Marco Lattarulo
Department of Urology, “S.S. Annunziata” Hospital, Taranto
3 shared publications - Arman Tsaturyan
Department of Urology, Erebouni Medical Center, Yerevan, Armenia
2 shared publications - Filippo Marino
Department of Urology, Humanitas Gavazzeni, 24125 Bergamo, Italy
2 shared publications
Latest Publications
- Open Access
Local Recurrence After Nephron Surgery: What to Do? An Italian Multicentric Registry
Introduction and Objectives: Local recurrence (LR) in patients treated with surgery for renal cell carcinoma (RCC) remains a significant clinical challenge that requires thorough investigation. Our study aimed to identify the relative risk factors and explore the optimal clinical management of LR. Materials and Methods: We conducted a non-randomized, observational, retrospective multicentric registry involving multiple Italian urological centers. We included patients treated with surgery (either nephron-sparing or radical nephrectomy) who later developed LR, defined as recurrence in the ipsilateral kidney or renal fossa. Patients with hereditary syndromes or metastatic disease at the time of LR diagnosis were excluded. Results: We reported 135 cases of LR with the following characteristics: most primary lesions were monofocal (85.7%), with a median size of 42 mm (23–53), the median R.E.N.A.L. score was 7 (6–8), and the median Padua score was 7 (6–9). Patients were treated with robot-assisted techniques in 59% of cases, laparoscopic surgery in 32.4%, and open surgery in 8.6%. Nephron-sparing surgery was performed in 75.2% of cases. Ischemia occurred in 61% of the cases, with a median ischemia time of 21 min (15.5–24). Intraoperative complications occurred in 3.8% of cases, while postoperative complications were reported in 13.8%, all of which were grade ≤3 according to the Clavien–Dindo classification. The primary tumors were pT1a in 43.5% of cases, pT1b in 26.3%, pT2 in 14.7% and pT3 in 15.5%. Histologically, 84% of cases were clear cell, 11.3% papillary type 1 or 2, and 3.7% chromophobe. Sarcomatoid/rhabdoid variants were present in 10.5% of cases. The median rate of LR was 1.3% (range 0.2–3.6), while the median time to LR was 18 months (12–39). LR occurred in the ipsilateral kidney in 70.5% of cases and in the ipsilateral renal fossa in 29.5%. The median rate of PSM in LR cases at initial surgery was 2.4% (range 0–4.3), while the median rate of negative surgical margin (NSM) in LR cases at initial surgery was 0.1 (0–0.3). Following LR diagnosis, most patients (49.2%) underwent surgery, 29.1% received cryoablation or radiotherapy, 17.1% received systemic treatment alone, and 4.6% followed a watchful waiting/active surveillance approach. At a median follow-up of 62 months, the highest oncological control in terms of 5-year cancer-specific survival and overall survival rates was achieved in surgically treated patients. The PSM, the histological variant, and their combination were found to be independent variables correlated with the occurrence of LR, with relative risks of 3.62, 2.71, and 8.12, respectively. Conclusions: LR after nephron-sparing or radical nephrectomy represents a significant clinical dilemma. Known risk factors are not always sufficient to predict recurrence, emphasizing the necessity of consistent radiological follow-up per guideline recommendations. Early detection of recurrence and a multidisciplinary approach involving expert centers are crucial for optimizing patient outcomes.
Open AccessLocal Recurrence After Nephron Surgery: What to Do? An Italian Multicentric Registry
Introduction and Objectives: Local recurrence (LR) in patients treated with surgery for renal cell carcinoma (RCC) remains a significant clinical challenge that requires thorough investigation. Our study aimed to identify the relative risk factors and explore the optimal clinical management of LR. Materials and Methods: We conducted a non-randomized, observational, retrospective multicentric registry involving multiple Italian urological centers. We included patients treated with surgery (either nephron-sparing or radical nephrectomy) who later developed LR, defined as recurrence in the ipsilateral kidney or renal fossa. Patients with hereditary syndromes or metastatic disease at the time of LR diagnosis were excluded. Results: We reported 135 cases of LR with the following characteristics: most primary lesions were monofocal (85.7%), with a median size of 42 mm (23–53), the median R.E.N.A.L. score was 7 (6–8), and the median Padua score was 7 (6–9). Patients were treated with robot-assisted techniques in 59% of cases, laparoscopic surgery in 32.4%, and open surgery in 8.6%. Nephron-sparing surgery was performed in 75.2% of cases. Ischemia occurred in 61% of the cases, with a median ischemia time of 21 min (15.5–24). Intraoperative complications occurred in 3.8% of cases, while postoperative complications were reported in 13.8%, all of which were grade ≤3 according to the Clavien–Dindo classification. The primary tumors were pT1a in 43.5% of cases, pT1b in 26.3%, pT2 in 14.7% and pT3 in 15.5%. Histologically, 84% of cases were clear cell, 11.3% papillary type 1 or 2, and 3.7% chromophobe. Sarcomatoid/rhabdoid variants were present in 10.5% of cases. The median rate of LR was 1.3% (range 0.2–3.6), while the median time to LR was 18 months (12–39). LR occurred in the ipsilateral kidney in 70.5% of cases and in the ipsilateral renal fossa in 29.5%. The median rate of PSM in LR cases at initial surgery was 2.4% (range 0–4.3), while the median rate of negative surgical margin (NSM) in LR cases at initial surgery was 0.1 (0–0.3). Following LR diagnosis, most patients (49.2%) underwent surgery, 29.1% received cryoablation or radiotherapy, 17.1% received systemic treatment alone, and 4.6% followed a watchful waiting/active surveillance approach. At a median follow-up of 62 months, the highest oncological control in terms of 5-year cancer-specific survival and overall survival rates was achieved in surgically treated patients. The PSM, the histological variant, and their combination were found to be independent variables correlated with the occurrence of LR, with relative risks of 3.62, 2.71, and 8.12, respectively. Conclusions: LR after nephron-sparing or radical nephrectomy represents a significant clinical dilemma. Known risk factors are not always sufficient to predict recurrence, emphasizing the necessity of consistent radiological follow-up per guideline recommendations. Early detection of recurrence and a multidisciplinary approach involving expert centers are crucial for optimizing patient outcomes.
- Open Access
- 28 July 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (3) , 13934
Strategies for preventing port-site hernia following robot-assisted radical prostatectomy: a systematic review
Background: Trocar site hernia is a recognized but often underreported complication of minimally invasive surgery, including robotic-assisted radical prostatectomy. While relatively rare, trocar site hernia can lead to severe complications such as bowel obstruction, strangulation, and the need for emergency surgical intervention. Trocar size has been identified as a primary risk factor, with hernias occurring predominantly at sites where 10 mm or larger trocars are used. However, the role of fascial closure is still debated.Methods and Results: A systematic literature review (1992-2022) identified 21 cases of trocar site hernia in 13 studies. Only 8 papers provided data on the total number of RaRP procedures which were associated to the reported cases of TSH, with 15 cases of TSH identified out of 3,418 RaRP procedures. Statistical analyses were conducted to assess significant risk factors and potential prevention strategies. Specifically, of the 19 cases in which trocar size was explicitly reported, 15 hernias were associated with 12 mm trocars and 4 with 8 mm trocars (p<0.001). Fascial closure was not performed in all reported cases involving 12 mm trocars. No significant correlations were found between trocar site hernia incidence and patient-related factors such as age, body mass index, or prior hernias. Additionally, we report a case of trocar site hernia following RARP in a 67-year-old male with a BMI of 33.46 and a history of prior abdominal hernioplasty. The patient developed bowel obstruction on postoperative day 4 due to a hernia at a 12 mm trocar site, requiring emergency laparotomy and bowel resection with end-to-end anastomosis.Conclusions: Given the strong association between TSH and 12 mm trocars, we suggest routine fascial closure at these sites to reduce the risk of postoperative complications. Further studies are necessary to confirm these findings. Additionally, other potential risk factors and mechanisms contributing to trocar site hernia development in patients undergoing robot-assisted radical prostatectomy should be investigated.
- 28 July 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (3) , 13934
Open AccessStrategies for preventing port-site hernia following robot-assisted radical prostatectomy: a systematic review
Background: Trocar site hernia is a recognized but often underreported complication of minimally invasive surgery, including robotic-assisted radical prostatectomy. While relatively rare, trocar site hernia can lead to severe complications such as bowel obstruction, strangulation, and the need for emergency surgical intervention. Trocar size has been identified as a primary risk factor, with hernias occurring predominantly at sites where 10 mm or larger trocars are used. However, the role of fascial closure is still debated.Methods and Results: A systematic literature review (1992-2022) identified 21 cases of trocar site hernia in 13 studies. Only 8 papers provided data on the total number of RaRP procedures which were associated to the reported cases of TSH, with 15 cases of TSH identified out of 3,418 RaRP procedures. Statistical analyses were conducted to assess significant risk factors and potential prevention strategies. Specifically, of the 19 cases in which trocar size was explicitly reported, 15 hernias were associated with 12 mm trocars and 4 with 8 mm trocars (p<0.001). Fascial closure was not performed in all reported cases involving 12 mm trocars. No significant correlations were found between trocar site hernia incidence and patient-related factors such as age, body mass index, or prior hernias. Additionally, we report a case of trocar site hernia following RARP in a 67-year-old male with a BMI of 33.46 and a history of prior abdominal hernioplasty. The patient developed bowel obstruction on postoperative day 4 due to a hernia at a 12 mm trocar site, requiring emergency laparotomy and bowel resection with end-to-end anastomosis.Conclusions: Given the strong association between TSH and 12 mm trocars, we suggest routine fascial closure at these sites to reduce the risk of postoperative complications. Further studies are necessary to confirm these findings. Additionally, other potential risk factors and mechanisms contributing to trocar site hernia development in patients undergoing robot-assisted radical prostatectomy should be investigated.
- Open Access
- 26 May 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- p. 13639
Recovery of functional outcomes after robot assisted radical prostatectomy (RaRP): impact of vacuum therapy compared to pde5 inhibitors alone
Objective: This study evaluated the primary efficacy of vacuum therapy combined with phosphodiesterase type 5 inhibitors (PDE5i) vs. PDE5i alone in improving erectile function recovery, assessed via the International Index of Erectile Function (IIEF) questionnaire, after robotic-assisted radical prostatectomy (RARP). A secondary objective was to assess the impact of the combined therapy on continence outcomes, including pad usage and continence scores. The study also explored predictors of rehabilitation success and the potential synergistic effects of the combined approach. Materials and methods: A retrospective analysis of 101 patients who underwent RARP (2021-2023) was conducted. Patients were divided into Group 1 (PDE5i only, n=70) and Group 2 (PDE5i + vacuum therapy, n=31). Vacuum therapy was started within 20 days postoperatively and performed daily under specialist supervision. All data were completely anonymous. Primary outcomes included IIEF-5 scores for erectile function and continence recovery (pad usage, continence scores based on three levels: 0 - complete incontinence, 1 - stress incontinence and 2 - full continence). Predictive factors were analysed using repeated measures ANOVA and multivariate regression. Results: Group 2 showed significantly higher mean IIEF-5 scores at 12 months (10.2 vs. 2.5, p<0.001) and earlier continence recovery, with better scores at 3 and 6 months (p < 0.05). Vacuum therapy and PDE5i accelerate continence recovery during the early postoperative period, with fewer pads required, compared with patients treated with PDE5i alone, at 6 months (1.32 vs. 1.62; p=0.358) and 9 months (0.54 vs. 1.08; p=0.034). Key predictors of recovery included age, BMI, nervesparing status, and preoperative continence levels.Conclusions: This study demonstrates the benefits of combining vacuum therapy with PDE5i for improving erectile function and early continence recovery after RARP, highlighting the importance of early, individualized rehabilitation. Vacuum therapy enhances oxygenation, reduces fibrosis and complements PDE5i effects. Further research is needed to refine predictive factors for success and explore the impact of intraoperative blood loss on erectile recovery, enabling optimized, tailored strategies for post-RARP rehabilitation.
- 26 May 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- p. 13639
Open AccessRecovery of functional outcomes after robot assisted radical prostatectomy (RaRP): impact of vacuum therapy compared to pde5 inhibitors alone
Objective: This study evaluated the primary efficacy of vacuum therapy combined with phosphodiesterase type 5 inhibitors (PDE5i) vs. PDE5i alone in improving erectile function recovery, assessed via the International Index of Erectile Function (IIEF) questionnaire, after robotic-assisted radical prostatectomy (RARP). A secondary objective was to assess the impact of the combined therapy on continence outcomes, including pad usage and continence scores. The study also explored predictors of rehabilitation success and the potential synergistic effects of the combined approach. Materials and methods: A retrospective analysis of 101 patients who underwent RARP (2021-2023) was conducted. Patients were divided into Group 1 (PDE5i only, n=70) and Group 2 (PDE5i + vacuum therapy, n=31). Vacuum therapy was started within 20 days postoperatively and performed daily under specialist supervision. All data were completely anonymous. Primary outcomes included IIEF-5 scores for erectile function and continence recovery (pad usage, continence scores based on three levels: 0 - complete incontinence, 1 - stress incontinence and 2 - full continence). Predictive factors were analysed using repeated measures ANOVA and multivariate regression. Results: Group 2 showed significantly higher mean IIEF-5 scores at 12 months (10.2 vs. 2.5, p<0.001) and earlier continence recovery, with better scores at 3 and 6 months (p < 0.05). Vacuum therapy and PDE5i accelerate continence recovery during the early postoperative period, with fewer pads required, compared with patients treated with PDE5i alone, at 6 months (1.32 vs. 1.62; p=0.358) and 9 months (0.54 vs. 1.08; p=0.034). Key predictors of recovery included age, BMI, nervesparing status, and preoperative continence levels.Conclusions: This study demonstrates the benefits of combining vacuum therapy with PDE5i for improving erectile function and early continence recovery after RARP, highlighting the importance of early, individualized rehabilitation. Vacuum therapy enhances oxygenation, reduces fibrosis and complements PDE5i effects. Further research is needed to refine predictive factors for success and explore the impact of intraoperative blood loss on erectile recovery, enabling optimized, tailored strategies for post-RARP rehabilitation.
- Open Access
- 26 May 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- p. 13640
Impact of laparoscopic experience on learning curves in robotic-assisted radical prostatectomy (RaRP): a comparative analysis of oncological and functional outcomes
Objective: This study aimed to evaluate the influence of prior laparoscopic experience on the learning curve and surgical outcomes of robotic-assisted radical prostatectomy (RaRP). Methods: A retrospective analysis was performed on 101 patients treated between 2021 and 2023. Two surgeons at the beginning of their robotic learning curves were compared: one with extensive prior laparoscopic experience and the other without such a background. Perioperative, oncological, and functional outcomes were assessed, with a specific focus on Pentafecta criteria. Statistical analyses and cumulative sum (CUSUM) charts were employed to evaluate performance trends and surgical outcomes. Results: Surgeon A, with substantial prior laparoscopic expertise, demonstrated shorter operative times (p = 0.015), reduced intraoperative blood loss, and superior early functional outcomes. Specifically, patients operated on by Surgeon A exhibited higher pad-free continence rates and improved erectile function recovery at 12 months postoperatively (p < 0.01). Additionally, nerve-sparing procedures performed by Surgeon A showed a trend toward fewer positive surgical margins, although this difference did not reach statistical significance. CUSUM analysis revealed more stable and consistent performance trends for Surgeon A in achieving Pentafecta outcomes compared to Surgeon B.Conclusions: Previous laparoscopic experience significantly contributes to shortening the learning curve for RaRP and enhancing early functional outcomes. This advantage is likely attributable to greater surgical anatomical knowledge. These findings highlight the importance of tailored training programs and the potential for skill transfer between laparoscopic and robotic approaches. Further studies are warranted to refine surgical education strategies and improve patient care outcomes.
- 26 May 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- p. 13640
Open AccessImpact of laparoscopic experience on learning curves in robotic-assisted radical prostatectomy (RaRP): a comparative analysis of oncological and functional outcomes
Objective: This study aimed to evaluate the influence of prior laparoscopic experience on the learning curve and surgical outcomes of robotic-assisted radical prostatectomy (RaRP). Methods: A retrospective analysis was performed on 101 patients treated between 2021 and 2023. Two surgeons at the beginning of their robotic learning curves were compared: one with extensive prior laparoscopic experience and the other without such a background. Perioperative, oncological, and functional outcomes were assessed, with a specific focus on Pentafecta criteria. Statistical analyses and cumulative sum (CUSUM) charts were employed to evaluate performance trends and surgical outcomes. Results: Surgeon A, with substantial prior laparoscopic expertise, demonstrated shorter operative times (p = 0.015), reduced intraoperative blood loss, and superior early functional outcomes. Specifically, patients operated on by Surgeon A exhibited higher pad-free continence rates and improved erectile function recovery at 12 months postoperatively (p < 0.01). Additionally, nerve-sparing procedures performed by Surgeon A showed a trend toward fewer positive surgical margins, although this difference did not reach statistical significance. CUSUM analysis revealed more stable and consistent performance trends for Surgeon A in achieving Pentafecta outcomes compared to Surgeon B.Conclusions: Previous laparoscopic experience significantly contributes to shortening the learning curve for RaRP and enhancing early functional outcomes. This advantage is likely attributable to greater surgical anatomical knowledge. These findings highlight the importance of tailored training programs and the potential for skill transfer between laparoscopic and robotic approaches. Further studies are warranted to refine surgical education strategies and improve patient care outcomes.
- Open Access
- 15 May 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- p. 13596
ChatGPT artificial intelligence in clinical data analysis: an example comparing standard vs fusion prostate biopsy outcomes after robotic-assisted radical prostatectomy (RaRP)
Objective: To compare statistical outputs from ChatGPT 4.0 and human experts in both comparative and correlation analyses in the evaluation of multiparametric MRI/ultrasound fusion-targeted biopsy plus random biopsy versus standard random biopsy alone, in terms of upstaging. Methods: Authors performed a retrospective evaluation on 101 patients undergoing robot-assisted radical prostatectomy (RaRP) between 2021 and 2023. Patients were divided in two groups, according to the type of prostatic biopsy received: combined fusion (MRI/US) targeted and random biopsy versus standard random biopsy. Clinical and histological data were anonymized and analyzed using logistic regression models, ANOVA, and Chi-square tests. Analysis generated by ChatGPT and by an experienced human statistician were compared. The Q-EVAL and Q-EVA tools were used to assess the quality of user-formulated questions and AI-generated answers, respectively.Results: Results revealed high concordance between statistical outputs generated by AI and expert human statistician with perfect concordance using Cohen’s kappa coefficient (κ = 1.0). Logistic regression analysis demonstrated that fusion biopsy was associated with a reduced likelihood of upstaging, a consistent finding across statistical evaluations. Additionally, user interaction assessments indicated high-quality in question formulation. Conclusions: ChatGPT (version 4.0) proved reliable for statistical analysis, showing strong concordance with human statisticians (κ = 1.0) in performing logistic regression, chi-square, and ANOVA tests. The Q-EVAL tool could reduce query errors, though ChatGPT's lack of automatic citations remains a limitation. Fusion biopsy significantly lowered upstaging risk after RaRP. In conclusion, ChatGPT is a valuable assistive tool but further research is required to optimize human-AI collaboration in clinical research.
- 15 May 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- p. 13596
Open AccessChatGPT artificial intelligence in clinical data analysis: an example comparing standard vs fusion prostate biopsy outcomes after robotic-assisted radical prostatectomy (RaRP)
Objective: To compare statistical outputs from ChatGPT 4.0 and human experts in both comparative and correlation analyses in the evaluation of multiparametric MRI/ultrasound fusion-targeted biopsy plus random biopsy versus standard random biopsy alone, in terms of upstaging. Methods: Authors performed a retrospective evaluation on 101 patients undergoing robot-assisted radical prostatectomy (RaRP) between 2021 and 2023. Patients were divided in two groups, according to the type of prostatic biopsy received: combined fusion (MRI/US) targeted and random biopsy versus standard random biopsy. Clinical and histological data were anonymized and analyzed using logistic regression models, ANOVA, and Chi-square tests. Analysis generated by ChatGPT and by an experienced human statistician were compared. The Q-EVAL and Q-EVA tools were used to assess the quality of user-formulated questions and AI-generated answers, respectively.Results: Results revealed high concordance between statistical outputs generated by AI and expert human statistician with perfect concordance using Cohen’s kappa coefficient (κ = 1.0). Logistic regression analysis demonstrated that fusion biopsy was associated with a reduced likelihood of upstaging, a consistent finding across statistical evaluations. Additionally, user interaction assessments indicated high-quality in question formulation. Conclusions: ChatGPT (version 4.0) proved reliable for statistical analysis, showing strong concordance with human statisticians (κ = 1.0) in performing logistic regression, chi-square, and ANOVA tests. The Q-EVAL tool could reduce query errors, though ChatGPT's lack of automatic citations remains a limitation. Fusion biopsy significantly lowered upstaging risk after RaRP. In conclusion, ChatGPT is a valuable assistive tool but further research is required to optimize human-AI collaboration in clinical research.